Karami, Azadeh <br/><br/>
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.  [electronic resource] 

 -  Alzheimer's & dementia : the journal of the Alzheimer's Association  Nov 2015 
 - 1316-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-5279 
<br/><br/><label>Standard No.: </label>10.1016/j.jalz.2014.11.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholinesterase--cerebrospinal fluid<br/>Aged<br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Biomarkers--cerebrospinal fluid<br/>Brain--diagnostic imaging<br/>Cell Transplantation<br/>Choline O-Acetyltransferase--cerebrospinal fluid<br/>Cognition--physiology<br/>Female<br/>Genetic Therapy--methods<br/>Glucose--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Nerve Growth Factor--genetics<br/>Radionuclide Imaging<br/>Tissue Scaffolds<br/>Treatment Outcome<br/>tau Proteins--cerebrospinal fluid